ReviewAnnals of translational medicine2020

Killer immunoglobulin-like receptors/human leukocyte antigen class-I, a crucial immune pathway in cancer.

Yi Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.